Broderick Brian C Novartis Ag Transaction History
Broderick Brian C
- $463 Million
- Q2 2025
A detailed history of Broderick Brian C transactions in Novartis Ag stock. As of the latest transaction made, Broderick Brian C holds 4,203 shares of NVS stock, worth $477,040. This represents 0.11% of its overall portfolio holdings.
Number of Shares
4,203
Previous 4,273
1.64%
Holding current value
$477,040
Previous $476,000
6.72%
% of portfolio
0.11%
Previous 0.11%
Shares
32 transactions
Others Institutions Holding NVS
# of Institutions
1,555Shares Held
142MCall Options Held
1.64MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.34 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.18 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$977 Million0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$801 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$768 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $244B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...